|
interprofessional education |
44 |
|
partnership model |
28 |
|
social interaction anxiety |
28 |
|
adult learning principles |
16 |
|
collaborative practice |
16 |
|
evaluation |
16 |
|
ischemic stroke |
10 |
|
caveolin-1 |
9 |
|
hypoxia |
9 |
|
animals |
8 |
|
nitric oxide |
8 |
|
oxidative stress |
8 |
|
alanine aminotransferase |
7 |
|
aspartate aminotransferase |
7 |
|
berberine - pharmacology - therapeutic use |
7 |
|
carbon tetrachloride |
7 |
|
coptidis rhizoma aqueous extract |
7 |
|
coptis - chemistry |
7 |
|
drug-induced liver injury - prevention and control |
7 |
|
drugs, chinese herbal - pharmacology - therapeutic use |
7 |
|
liver - drug effects - pathology |
7 |
|
liver histopathology |
7 |
|
male |
7 |
|
rats |
7 |
|
rats, sprague-dawley |
7 |
|
superoxide dismutase |
7 |
|
cellular neuroscience |
6 |
|
cerebral ischemia |
6 |
|
electron spin resonance spectroscopy - methods |
6 |
|
enzyme inhibitors - pharmacology |
6 |
|
mitophagy |
6 |
|
molecular neuroscience |
6 |
|
neuroscience |
6 |
|
peroxynitrite |
6 |
|
ros |
6 |
|
adipocyte |
5 |
|
adipocytes - metabolism |
5 |
|
adiponectin - biosynthesis - metabolism |
5 |
|
adiponectin and adipokine |
5 |
|
anoxia - metabolism |
5 |
|
apoptosis |
5 |
|
apoptosis - drug effects |
5 |
|
breast cancer |
5 |
|
fabaceae - chemistry |
5 |
|
neurogenesis |
5 |
|
nitric oxide synthase |
5 |
|
nitric oxide synthase - antagonists & inhibitors |
5 |
|
obesity |
5 |
|
plasminogen activator inhibitor 1 - biosynthesis |
5 |
|
reactive oxygen species |
5 |
|
reactive oxygen species - metabolism |
5 |
|
traditional chinese medicine |
5 |
|
adult neurogenesis |
4 |
|
algorithms |
4 |
|
baicalin |
4 |
|
biological response fingerprinting |
4 |
|
blind source separation |
4 |
|
botanical drug products |
4 |
|
brain ischemia - physiopathology |
4 |
|
cancer stem cells |
4 |
|
caveolin 1 - genetics - metabolism |
4 |
|
caveolin 1 - metabolism |
4 |
|
cell differentiation - genetics - physiology |
4 |
|
chromatography, high pressure liquid |
4 |
|
cost-benefit analysis |
4 |
|
dna microarray |
4 |
|
dnmt1 |
4 |
|
drugs, chinese herbal - standards |
4 |
|
electron paramagnetic resonance |
4 |
|
experimental autoimmune encephalomyelitis |
4 |
|
free radical |
4 |
|
gene expression regulation - drug effects |
4 |
|
gene regulation |
4 |
|
genes, plant |
4 |
|
heme oxygenase-1 |
4 |
|
herbal medicine |
4 |
|
inflammation |
4 |
|
isoliquiritigenin |
4 |
|
kidney - chemistry |
4 |
|
mammary tumorigenesis |
4 |
|
multiple sclerosis |
4 |
|
neural stem cells - cytology - metabolism |
4 |
|
neuroprotection |
4 |
|
ng-nitroarginine methyl ester - pharmacology |
4 |
|
nitric oxide - physiology |
4 |
|
nitric oxide donors - pharmacology |
4 |
|
ornithine - analogs & derivatives - pharmacology |
4 |
|
qrt-pcr |
4 |
|
quality control |
4 |
|
reactive nitrogen species |
4 |
|
reperfusion injury - physiopathology |
4 |
|
reverse transcriptase polymerase chain reaction - methods |
4 |
|
signal processing, computer-assisted |
4 |
|
signal transduction - genetics - physiology |
4 |
|
stroke |
4 |
|
vascular endothelial growth factor a - genetics - metabolism |
4 |
|
wif1 demethylation |
4 |
|
ace2 |
3 |
|
acteoside |
3 |
|
alisol b 23-acetate |
3 |
|
animal experiment |
3 |
|
animal tissue |
3 |
|
anti-coronavirus |
3 |
|
anti-immunoinflammatory activity |
3 |
|
antineoplastic agents - pharmacology |
3 |
|
antineoplastic agents, phytogenic - pharmacology |
3 |
|
appl2 |
3 |
|
arkadia |
3 |
|
astrocyte |
3 |
|
behavior |
3 |
|
bioimaging |
3 |
|
blood-brain barrier |
3 |
|
blood-brain barrier - physiopathology |
3 |
|
brain ischemia - enzymology - physiopathology |
3 |
|
brain microvascular endothelial cells |
3 |
|
breast and colon cancer |
3 |
|
caveolin 1 - physiology |
3 |
|
cell cycle |
3 |
|
cells, cultured |
3 |
|
cerebral ischemia-reperfusion injury |
3 |
|
chemiluminescence |
3 |
|
corticosterone |
3 |
|
covid-19 |
3 |
|
cyclic n-oxides |
3 |
|
depression |
3 |
|
dioscin |
3 |
|
diosgenin - analogs and derivatives - pharmacology |
3 |
|
down-regulation - drug effects |
3 |
|
drugs, chinese herbal - pharmacology |
3 |
|
epr spectroscopy |
3 |
|
esophageal cancer |
3 |
|
ferroptosis |
3 |
|
fibrosis |
3 |
|
fluorescent probes |
3 |
|
free radicals - chemistry |
3 |
|
glucocorticoid receptor |
3 |
|
glycyrrhetinic acid |
3 |
|
hes1 |
3 |
|
hippocampus |
3 |
|
hydrogen peroxide |
3 |
|
hydroxyl radical - chemistry |
3 |
|
imaging agents |
3 |
|
ischemia |
3 |
|
latent tgf-β1 |
3 |
|
ldh-a |
3 |
|
lycium extract |
3 |
|
matrix metalloproteinases - metabolism |
3 |
|
mitochondrion |
3 |
|
nadph oxidasei |
3 |
|
naringin |
3 |
|
neoplasms - drug therapy - metabolism - pathology |
3 |
|
neural progenitor cells |
3 |
|
neuroblastoma cells |
3 |
|
nitric oxide - chemistry |
3 |
|
nitric oxide - metabolism |
3 |
|
nitric oxide synthases |
3 |
|
notch1 |
3 |
|
nrf2 |
3 |
|
oligodendrocytes |
3 |
|
peroxiredoxins |
3 |
|
peroxiredoxins - genetics - metabolism |
3 |
|
phytotherapy |
3 |
|
pinosylvin |
3 |
|
polysaccharide |
3 |
|
proliferation |
3 |
|
quantitative spectroscopy analysis |
3 |
|
reperfusion injury - enzymology - physiopathology |
3 |
|
rns |
3 |
|
smad7 |
3 |
|
sparse component analysis |
3 |
|
spatholobus suberectus |
3 |
|
spin trapping |
3 |
|
superoxides - chemistry |
3 |
|
β-catenin |
3 |
|
3t3-l1 |
2 |
|
adr |
2 |
|
ae |
2 |
|
against breast cancer cell lines |
2 |
|
agnh pill |
2 |
|
amp-activated protein kinase |
2 |
|
angong niuhuang wan |
2 |
|
anti-angiogenesis |
2 |
|
antineoplastic agents - chemistry - pharmacology |
2 |
|
antioxidants |
2 |
|
antiproliferative activity |
2 |
|
arsenic |
2 |
|
artificial intelligence (ai) |
2 |
|
astrocytes |
2 |
|
autoimmune |
2 |
|
autophagy |
2 |
|
bcl-2 |
2 |
|
biological activity |
2 |
|
brain - metabolism |
2 |
|
brain derived neurotrophic factor |
2 |
|
brain edema |
2 |
|
breast neoplasms - pathology |
2 |
|
buyang huanwu decoction |
2 |
|
cajaninstilbene acid |
2 |
|
cancer therapy |
2 |
|
cardiomyocytes |
2 |
|
caveolins |
2 |
|
cell proliferation |
2 |
|
cell therapy |
2 |
|
chinese herbal medicine |
2 |
|
chinese medicine |
2 |
|
cho cells - chemistry |
2 |
|
cholesterol |
2 |
|
cholesterol - genetics - metabolism |
2 |
|
chronic heart failure |
2 |
|
cinnabar |
2 |
|
conjugated linoleic acid |
2 |
|
contrast media - pharmacokinetics |
2 |
|
cricetinae |
2 |
|
cricetulus |
2 |
|
curcuma longa |
2 |
|
cyclic n-oxides - analysis - chemistry |
2 |
|
delivery tool |
2 |
|
drp1 |
2 |
|
dynamin-related protein 1 |
2 |
|
electroconvulsive therapy |
2 |
|
ellagic acid |
2 |
|
endothelium |
2 |
|
epr imaging |
2 |
|
flavonoids |
2 |
|
flk1 |
2 |
|
focal cerebral ischaemia |
2 |
|
free radicals - analysis - chemistry |
2 |
|
free radicals - metabolism |
2 |
|
genetic modification |
2 |
|
glycolysis |
2 |
|
glycyrrhizin |
2 |
|
grp78 |
2 |
|
heavy metal toxicity |
2 |
|
hemorrhagic transformation |
2 |
|
hemorrhagic transformation (ht) |
2 |
|
high mobility group box protein 1 (hmgb1) |
2 |
|
hydroxycoumarin |
2 |
|
hydroxyl radical - analysis - chemistry |
2 |
|
hypoxia-reoxygenation |
2 |
|
icam-1 |
2 |
|
immunohistochemistry |
2 |
|
independent component analysis |
2 |
|
inflammatory factors |
2 |
|
irritable bowel syndrome |
2 |
|
l-lactate dehydrogenase - antagonists and inhibitors - genetics |
2 |
|
lipid metabolism |
2 |
|
lymphocyte trafficking |
2 |
|
marine algae extract |
2 |
|
mental disorders |
2 |
|
mesenchymal stem cells |
2 |
|
metabolism factors |
2 |
|
mice |
2 |
|
mice, inbred c57bl |
2 |
|
molecular docking |
2 |
|
molecular probe techniques |
2 |
|
mouse brain |
2 |
|
natural compound |
2 |
|
natural medicine |
2 |
|
neoisoliquiritigenin |
2 |
|
neural stem/progenitor cells |
2 |
|
neural stem/progenitor cells (nscs) |
2 |
|
neurogenic niche |
2 |
|
neuronal damages |
2 |
|
neuronal differentiation |
2 |
|
neurons - metabolism |
2 |
|
new substituted 5-hydroxycoumarin |
2 |
|
nitration |
2 |
|
nitrative stress |
2 |
|
nitric oxide - analysis - chemistry |
2 |
|
nitrogen oxides - diagnostic use - pharmacokinetics |
2 |
|
nitroxide |
2 |
|
notch1 signaling |
2 |
|
olfactory bulb |
2 |
|
olfactory functions |
2 |
|
osteoporosis |
2 |
|
osteoprotegerin |
2 |
|
oxidative stress - drug effects |
2 |
|
oximetry - methods |
2 |
|
oxygen consumption - physiology |
2 |
|
oxygen measurement |
2 |
|
p53 |
2 |
|
pancreatic cancer |
2 |
|
parp-1 |
2 |
|
peroxynitrite (onoo−) |
2 |
|
pharmacological properties |
2 |
|
progression |
2 |
|
psychiatric diseases |
2 |
|
pyranocoumarin |
2 |
|
qiliqiangxin (qlqx) capsule |
2 |
|
reactive oxygen species - analysis - chemistry |
2 |
|
realgar |
2 |
|
rehmapicroside |
2 |
|
safety |
2 |
|
schizophrenia |
2 |
|
self-renewal |
2 |
|
solutions - analysis - chemistry |
2 |
|
spectroscopy analysis |
2 |
|
subarachnoid hemorrhage |
2 |
|
subventricular zone |
2 |
|
superoxide |
2 |
|
superoxides - analysis - chemistry |
2 |
|
superoxides - metabolism |
2 |
|
syndrome |
2 |
|
syndrome element |
2 |
|
syndrome questionnaire |
2 |
|
systematic review |
2 |
|
tissue plasminogen activator (t-pa) |
2 |
|
traditional chinese medicine (tcm) |
2 |
|
vasospasm |
2 |
|
vcam-1 |
2 |
|
vegf |
2 |
|
vegf/vegfr2 |
2 |
|
β-catenin signaling |
2 |
|
(nf-κb) signaling pathway |
1 |
|
activator protein-1 |
1 |
|
acupuncture |
1 |
|
acupuncture therapy - adverse effects |
1 |
|
acute lung injury |
1 |
|
administration, oral |
1 |
|
adult |
1 |
|
aged |
1 |
|
airway hyperresponsiveness |
1 |
|
alkaloids |
1 |
|
allopathy |
1 |
|
alpinia oxyphylla miq |
1 |
|
ampk/sirt1 signaling |
1 |
|
animals, newborn |
1 |
|
annexin a5 - analysis |
1 |
|
anti-inflammation |
1 |
|
anti-inflammatory |
1 |
|
anti-inflammatory effect |
1 |
|
anticarcinogenic agents - chemistry - pharmacology |
1 |
|
antioxidant |
1 |
|
antioxidation |
1 |
|
antitumor-promoting activity |
1 |
|
antiviral agents - chemistry - pharmacology |
1 |
|
apoplectic hemiparalysis |
1 |
|
apoplexy (脑卒中) |
1 |
|
apoptosis - drug effects - physiology |
1 |
|
aquaporin-4 |
1 |
|
arginine - analogs & derivatives - pharmacology |
1 |
|
astragali radix |
1 |
|
astragaloside vi |
1 |
|
astragalus membranaceus (內蒙黃芪) |
1 |
|
astragalus species |
1 |
|
atherosclerosis |
1 |
|
autoxidation (自氧化) |
1 |
|
bdnf |
1 |
|
bdnf/trkb/erk/creb pathway |
1 |
|
bioactive constituents |
1 |
|
biochemistry |
1 |
|
biodiesel |
1 |
|
biological markers |
1 |
|
biology |
1 |
|
biophysics chemistry |
1 |
|
blood brain barrier (血脑屏障) |
1 |
|
blood-brain barrier - drug effects |
1 |
|
blood-brain barrier - metabolism |
1 |
|
blood–brain barrier |
1 |
|
blotting, western |
1 |
|
brain - blood supply |
1 |
|
brain ischemia |
1 |
|
brain ischemia - metabolism - therapy |
1 |
|
brain-derived neurotrophic factor |
1 |
|
bromodeoxyuridine - metabolism - pharmacokinetics |
1 |
|
bushen-yizhi formula |
1 |
|
buyang huanwu decoction (補陽還五湯) |
1 |
|
c5a-c5ar1 |
1 |
|
calyscosin-7-o-β-d-glucoside |
1 |
|
capillaries - drug effects - physiology |
1 |
|
cardiovascular diseases (cvds) |
1 |
|
catalase - pharmacology |
1 |
|
caveolin1 |
1 |
|
caveolin2 |
1 |
|
cell death |
1 |
|
cell differentiation |
1 |
|
cell division - drug effects |
1 |
|
cell hypoxia |
1 |
|
cell hypoxia - drug effects |
1 |
|
cell hypoxia - drug effects - physiology |
1 |
|
cell proliferation - drug effects |
1 |
|
cell toxicity |
1 |
|
central nervous system agents |
1 |
|
cerebral cortex - cytology |
1 |
|
cerebral cortex - pathology |
1 |
|
cerebral ischemia-reperfusion injury (脑缺血再灌注损伤) |
1 |
|
cerebral ischemia–reperfusion injury |
1 |
|
cerebral ischemic/tcm therapy |
1 |
|
chemical components |
1 |
|
chemical constituents (化學成份) |
1 |
|
chinese drug |
1 |
|
chinonin |
1 |
|
cholesterol efflux |
1 |
|
chronic pulmonary neutrophilic inflammation |
1 |
|
chrysomya megacephala larvae |
1 |
|
cigarette smoke |
1 |
|
classification model |
1 |
|
clinical effectiveness |
1 |
|
collagen iv |
1 |
|
colorectal neoplasms/pathology |
1 |
|
coloring agents |
1 |
|
combination therapy |
1 |
|
coronary disease - blood - drug therapy |
1 |
|
cough |
1 |
|
coumarins |
1 |
|
creb3l1 |
1 |
|
crystallography biology |
1 |
|
cyclin-dependent kinase inhibitor p21 - metabolism |
1 |
|
d-galactose-induced-aging rats |
1 |
|
daidzein (大豆苷元) |
1 |
|
danggui-shaoyao-san |
1 |
|
danshensu (丹參素) |
1 |
|
daphne - chemistry |
1 |
|
daphne species |
1 |
|
deep learning (dl) |
1 |
|
diabetes |
1 |
|
diabetic nephropathy |
1 |
|
differentiation |
1 |
|
dna fragmentation - drug effects |
1 |
|
docking |
1 |
|
droplet dispensing |
1 |
|
drug safety |
1 |
|
drugs, chinese herbal - administration & dosage - therapeutic use |
1 |
|
drugs, chinese herbal - therapeutic use |
1 |
|
electrochemical sensors |
1 |
|
electron paramagnetic resonance imaging |
1 |
|
electron spin resonance |
1 |
|
electron spin resonance spectroscopy |
1 |
|
endoplasmic reticulum stress |
1 |
|
enzyme-linked immunosorbent assay |
1 |
|
epidermal growth factor |
1 |
|
epithelium growth factor |
1 |
|
epithelium growth factor receptor |
1 |
|
erythropoietin-producing hepatoma cell line-b2 |
1 |
|
esr |
1 |
|
estrogen receptor |
1 |
|
evans blue |
1 |
|
evidence-based questionnaire |
1 |
|
expert consensus |
1 |
|
female |
1 |
|
fibrinolysis - drug effects |
1 |
|
flavones |
1 |
|
flexible sensors |
1 |
|
flow cytometry |
1 |
|
focal ischemia |
1 |
|
free radical scavengers - pharmacology |
1 |
|
free radicals |
1 |
|
fuel properties |
1 |
|
gelatin - metabolism |
1 |
|
genes, bcl-2 |
1 |
|
genes, p53 |
1 |
|
ginkgo biloba |
1 |
|
glucosides form shaoyao gancao decoction |
1 |
|
glycosides - pharmacology |
1 |
|
graphene oxide |
1 |
|
gsk-3β |
1 |
|
heart - drug effects |
1 |
|
heart - drug effects - physiology - physiopathology |
1 |
|
heart failure |
1 |
|
heat shock protein 65 |
1 |
|
heavy metal |
1 |
|
hemiparalysis (偏瘫) |
1 |
|
hemoglobins - metabolism |
1 |
|
hemorrhage |
1 |
|
hepatic ischemia/reperfusion |
1 |
|
hepatocellular carcinoma |
1 |
|
hexadecanoic (軟脂酸甘油脂) |
1 |
|
high density lipoprotein |
1 |
|
hightest occupied molecular orbital |
1 |
|
hippocampal neurogenesis |
1 |
|
hippocampus - drug effects - metabolism - pathology |
1 |
|
histone deacetylase 2 |
1 |
|
hmgb1 |
1 |
|
hmgb1-binding heptamer peptide |
1 |
|
ht |
1 |
|
human pulse sensing |
1 |
|
humans |
1 |
|
hydrogen peroxide electrode (過氧化氫電極) |
1 |
|
hydroxysafflor yellow a (hsya) |
1 |
|
hypertension - blood - drug therapy |
1 |
|
iemg |
1 |
|
infarction, middle cerebral artery - drug therapy - physiopathology |
1 |
|
infarction, middle cerebral artery - metabolism - pathology |
1 |
|
innate immune receptors |
1 |
|
inos |
1 |
|
integrate electromyography(iemg) (电积分值肌) |
1 |
|
intracranial hemorrhage, hypertensive - complications - mortality - therapy |
1 |
|
ischemia-reperfusion injury |
1 |
|
ischemia-reperfusion injury of myocardium |
1 |
|
ischemic attack, transient - metabolism - pathology |
1 |
|
ischemic postconditioning - methods |
1 |
|
ischemic preconditioning - methods |
1 |
|
isoflavones |
1 |
|
isolation |
1 |
|
jiejing mixture (解痉合剂肌) |
1 |
|
jnk signaling pathway |
1 |
|
kinase |
1 |
|
kinetics |
1 |
|
l-lactate dehydrogenase - analysis |
1 |
|
l-lactate dehydrogenase - metabolism |
1 |
|
lignans |
1 |
|
lipid peroxidation - drug effects |
1 |
|
lipid peroxides - analysis - blood |
1 |
|
lipid peroxides - blood |
1 |
|
lipoxin a4 |
1 |
|
liver injury |
1 |
|
lps |
1 |
|
lumbrokinase |
1 |
|
luminescent measurements |
1 |
|
machine learning |
1 |
|
machine learning (ml) |
1 |
|
macrophage |
1 |
|
malaria - drug therapy |
1 |
|
matrix metalloproteinase 2 - metabolism |
1 |
|
matrix metalloproteinase 9 - antagonists & inhibitors - physiology |
1 |
|
matrix metalloproteinases |
1 |
|
matrix metalloproteinsases |
1 |
|
mechanism |
1 |
|
medical sciences |
1 |
|
medicine, chinese traditional |
1 |
|
membrane proteins - metabolism |
1 |
|
mental disorder |
1 |
|
meta-analysis |
1 |
|
metabolism |
1 |
|
metabolomics |
1 |
|
microvessel |
1 |
|
middle aged |
1 |
|
mitochondria |
1 |
|
mitochondria - physiology |
1 |
|
mitochondria/ultrastructure |
1 |
|
mitochondrial dysfunction |
1 |
|
mmp-2 |
1 |
|
mmp-9 |
1 |
|
mmps |
1 |
|
momordica charantia polysaccharide |
1 |
|
momordica charantia polysaccharides (mcps) |
1 |
|
muc5ac |
1 |
|
mucus hypersecretion |
1 |
|
multi-target |
1 |
|
myeloperoxidase |
1 |
|
myocardial ischemia - drug therapy |
1 |
|
myocardial ischemia - metabolism - prevention & control |
1 |
|
myocardial ischemia - pathology |
1 |
|
myocardial reperfusion injury - drug therapy |
1 |
|
myocardial reperfusion injury - metabolism - prevention & control |
1 |
|
myocardial reperfusion injury - pathology |
1 |
|
myocardium - chemistry - cytology - pathology |
1 |
|
myocardium - metabolism |
1 |
|
myocardium - pathology |
1 |
|
myocytes, cardiac - cytology - drug effects |
1 |
|
myocytes, cardiac - cytology - drug effects - metabolism |
1 |
|
nanoparticles |
1 |
|
natural compounds |
1 |
|
necrosis |
1 |
|
nervous system diseases - etiology |
1 |
|
network pharmacology |
1 |
|
neural stem cell |
1 |
|
neural stem cells |
1 |
|
neural stem cells (nscs) |
1 |
|
neurodegeneration |
1 |
|
neurogenesis (神经再生) |
1 |
|
neuroinflammation |
1 |
|
neurological diseases |
1 |
|
neurons - cytology - drug effects |
1 |
|
neurons - drug effects - metabolism - pathology |
1 |
|
neuroprotective agents - administration & dosage - therapeutic use |
1 |
|
neuroprotective agents - therapeutic use |
1 |
|
neurotoxicity |
1 |
|
ng-nitroarginine methyl ester |
1 |
|
ngf |
1 |
|
nitrates - analysis |
1 |
|
nitrative damage |
1 |
|
nitric oxide (一氧化氮) |
1 |
|
nitric oxide - blood |
1 |
|
nitric oxide - metabolism - pharmacology |
1 |
|
nitrites - analysis |
1 |
|
nitroprusside - pharmacology |
1 |
|
nitrotyrosine |
1 |
|
nitrous oxide |
1 |
|
nitroxides |
1 |
|
niuhuang qingxin wan |
1 |
|
no |
1 |
|
nuclear factor kappa b |
1 |
|
o 2 |
1 |
|
oct-4 |
1 |
|
oncogene protein p21(ras) - biosynthesis - genetics |
1 |
|
optimization |
1 |
|
oxidation-reduction |
1 |
|
oxidative/nitrosative stress |
1 |
|
oxygen |
1 |
|
oxygen - metabolism |
1 |
|
oxygen - pharmacology |
1 |
|
oxygen free radical |
1 |
|
oxygen free radicals |
1 |
|
oxygen inhalation therapy |
1 |
|
oxygen radical |
1 |
|
p-coumaric acid |
1 |
|
p21/waf1/cip1 |
1 |
|
palpation |
1 |
|
paraquat |
1 |
|
patient safety |
1 |
|
perk-eif2α-atf4 pathway |
1 |
|
peroxynitrite (过氧亚硝基) |
1 |
|
plant extracts - chemistry - pharmacology |
1 |
|
plant extracts - pharmacology |
1 |
|
plasminogen - pharmacokinetics |
1 |
|
plasminogen activator inhibitor 1 - pharmacokinetics |
1 |
|
postconditioning |
1 |
|
pratensein (紅車軸草素) |
1 |
|
preconditioning |
1 |
|
predictive factor |
1 |
|
privileged substructures |
1 |
|
probes |
1 |
|
programmed cell death |
1 |
|
proliferation of rat mesenchymal stem cells (mscs) |
1 |
|
prooxidation (促氧化) |
1 |
|
protective agents - pharmacology |
1 |
|
proto-oncogene proteins c-bcl-2 - metabolism |
1 |
|
publication bias |
1 |
|
pulmonary fibrosis |
1 |
|
pulse diagnosis |
1 |
|
pulse pattern recognition |
1 |
|
qingyihuaji formula |
1 |
|
quantum chemistry |
1 |
|
rabbits |
1 |
|
radix rehmanniae |
1 |
|
random allocation |
1 |
|
rats, wistar |
1 |
|
reactive nitrogen species (rns) |
1 |
|
reactive nitrogen species (活性氮自由基) |
1 |
|
reactive oxygen species - metabolism - pharmacology |
1 |
|
reoxygenation |
1 |
|
reperfusion injury - metabolism |
1 |
|
reperfusion injury - metabolism - pathology |
1 |
|
response surface evaluation |
1 |
|
review |
1 |
|
rms |
1 |
|
rock |
1 |
|
rock ii inhibitors |
1 |
|
sanwei ganjiang prescription |
1 |
|
scalp |
1 |
|
scalp acupuncture |
1 |
|
serum-free medium culture |
1 |
|
si-wu decoction |
1 |
|
signal transduction |
1 |
|
sirt1 |
1 |
|
smoke |
1 |
|
snps |
1 |
|
solid phase extraction |
1 |
|
spasticity |
1 |
|
spasticity (肌痉挛) |
1 |
|
src |
1 |
|
steroids |
1 |
|
superoxide anion (超氧陰離子) |
1 |
|
superoxide dismutase - analysis - blood |
1 |
|
superoxide dismutase - blood |
1 |
|
syndrome differentiation |
1 |
|
synergism |
1 |
|
systems pharmacology |
1 |
|
tactile sensor |
1 |
|
tanshinone ii a |
1 |
|
tcm syndromes |
1 |
|
terpenoids |
1 |
|
therapeutic compounds |
1 |
|
thiobarbituric acid reactive substances - analysis |
1 |
|
thiobarbituric acid reactive substances - metabolism |
1 |
|
tight junction proteins |
1 |
|
tight junctions - drug effects |
1 |
|
time factors |
1 |
|
tissue plasminogen activator |
1 |
|
tissue plasminogen activator - blood |
1 |
|
tongue analysis |
1 |
|
transesterification |
1 |
|
transient cerebral ischemia |
1 |
|
triterpenoids |
1 |
|
tumor suppressor protein p53 - biosynthesis - genetics |
1 |
|
tumor suppressor protein p53 - metabolism |
1 |
|
vascular calcification |
1 |
|
x-ray repair cross-complementing group 1 |
1 |
|
xanthenes - pharmacology |
1 |
|
xanthine oxidase - metabolism |
1 |
|
zinc |
1 |
|
倍他司汀 |
1 |
|
免疫印迹法 |
1 |
|
大鼠脑微血管内皮细胞 |
1 |
|
水通道蛋白 |
1 |
|
管石復位法 |
1 |
|
缺氧缺糖 |
1 |
|
缺血性脑水肿 |
1 |
|
良性陣發性位置性眩暈 (bppv) |
1 |
|
豁痰健脾法 |
1 |
